 | • レポートコード：D0GIR-12810 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、結核ワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。結核ワクチンの種類別市場規模（免疫療法ワクチン、ブースターワクチン、その他）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Sanofi、Taj Pharmaceuticals、GlaxoSmithKline、Merck、GreenSignal Bio Pharma、Serum Institute of India、China National Biotec Group、IDT Biologics、Japan BCG Lab、Bavarian Nordic ・地域別グローバル市場分析 2015年-2020年 ・結核ワクチンの北米市場（アメリカ、カナダ、メキシコ） ・結核ワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・結核ワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・結核ワクチンの南米市場（ブラジル、アルゼンチン） ・結核ワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：免疫療法ワクチン、ブースターワクチン、その他 ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Tuberculosis Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Tuberculosis Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Tuberculosis Vaccines market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Tuberculosis Vaccines market has been segmented into
Immunotherapeutic Vaccines
Booster Vaccines
Others
By Application, Tuberculosis Vaccines has been segmented into:
Hospitals
Clinics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Tuberculosis Vaccines market presented in the report. This section sheds light on the sales growth of different regional and country-level Tuberculosis Vaccines markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Tuberculosis Vaccines market.
The report offers in-depth assessment of the growth and other aspects of the Tuberculosis Vaccines market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Tuberculosis Vaccines Market Share Analysis
Tuberculosis Vaccines competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Tuberculosis Vaccines sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Tuberculosis Vaccines sales, revenue and market share for each player covered in this report.
The major players covered in Tuberculosis Vaccines are:
Sanofi
Taj Pharmaceuticals
GlaxoSmithKline
Merck
GreenSignal Bio Pharma
Serum Institute of India
China National Biotec Group
IDT Biologics
Japan BCG Lab
Bavarian Nordic
Among other players domestic and global, Tuberculosis Vaccines market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tuberculosis Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Tuberculosis Vaccines, with price, sales, revenue and global market share of Tuberculosis Vaccines in 2018 and 2019.
Chapter 3, the Tuberculosis Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tuberculosis Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Tuberculosis Vaccines market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Tuberculosis Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Tuberculosis Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Tuberculosis Vaccines Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Immunotherapeutic Vaccines
1.2.3 Booster Vaccines
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Tuberculosis Vaccines Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Overview of Global Tuberculosis Vaccines Market
1.4.1 Global Tuberculosis Vaccines Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Taj Pharmaceuticals
2.2.1 Taj Pharmaceuticals Details
2.2.2 Taj Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Taj Pharmaceuticals SWOT Analysis
2.2.4 Taj Pharmaceuticals Product and Services
2.2.5 Taj Pharmaceuticals Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GlaxoSmithKline SWOT Analysis
2.3.4 GlaxoSmithKline Product and Services
2.3.5 GlaxoSmithKline Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck
2.4.1 Merck Details
2.4.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck SWOT Analysis
2.4.4 Merck Product and Services
2.4.5 Merck Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 GreenSignal Bio Pharma
2.5.1 GreenSignal Bio Pharma Details
2.5.2 GreenSignal Bio Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 GreenSignal Bio Pharma SWOT Analysis
2.5.4 GreenSignal Bio Pharma Product and Services
2.5.5 GreenSignal Bio Pharma Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Serum Institute of India
2.6.1 Serum Institute of India Details
2.6.2 Serum Institute of India Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Serum Institute of India SWOT Analysis
2.6.4 Serum Institute of India Product and Services
2.6.5 Serum Institute of India Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 China National Biotec Group
2.7.1 China National Biotec Group Details
2.7.2 China National Biotec Group Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 China National Biotec Group SWOT Analysis
2.7.4 China National Biotec Group Product and Services
2.7.5 China National Biotec Group Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 IDT Biologics
2.8.1 IDT Biologics Details
2.8.2 IDT Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 IDT Biologics SWOT Analysis
2.8.4 IDT Biologics Product and Services
2.8.5 IDT Biologics Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Japan BCG Lab
2.9.1 Japan BCG Lab Details
2.9.2 Japan BCG Lab Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Japan BCG Lab SWOT Analysis
2.9.4 Japan BCG Lab Product and Services
2.9.5 Japan BCG Lab Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bavarian Nordic
2.10.1 Bavarian Nordic Details
2.10.2 Bavarian Nordic Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bavarian Nordic SWOT Analysis
2.10.4 Bavarian Nordic Product and Services
2.10.5 Bavarian Nordic Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Tuberculosis Vaccines Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Tuberculosis Vaccines Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Tuberculosis Vaccines Manufacturer Market Share in 2019
3.3.2 Top 6 Tuberculosis Vaccines Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Tuberculosis Vaccines Sales, Revenue and Market Share by Regions
4.1.1 Global Tuberculosis Vaccines Sales and Market Share by Regions (2015-2020)
4.1.2 Global Tuberculosis Vaccines Revenue and Market Share by Regions (2015-2020)
4.2 North America Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
4.3 Europe Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
4.5 South America Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Tuberculosis Vaccines Sales, Revenue and Market Share by Country
5.1.1 North America Tuberculosis Vaccines Sales and Market Share by Country (2015-2020)
5.1.2 North America Tuberculosis Vaccines Revenue and Market Share by Country (2015-2020)
5.2 United States Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
5.3 Canada Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
5.4 Mexico Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Tuberculosis Vaccines Sales, Revenue and Market Share by Country
6.1.1 Europe Tuberculosis Vaccines Sales and Market Share by Country (2015-2020)
6.1.2 Europe Tuberculosis Vaccines Revenue and Market Share by Country (2015-2020)
6.2 Germany Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
6.3 UK Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
6.4 France Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
6.5 Russia Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
6.6 Italy Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Tuberculosis Vaccines Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Tuberculosis Vaccines Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Tuberculosis Vaccines Revenue and Market Share by Regions (2015-2020)
7.2 China Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
7.3 Japan Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
7.4 Korea Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
7.5 India Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
7.7 Australia Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Tuberculosis Vaccines Sales, Revenue and Market Share by Country
8.1.1 South America Tuberculosis Vaccines Sales and Market Share by Country (2015-2020)
8.1.2 South America Tuberculosis Vaccines Revenue and Market Share by Country (2015-2020)
8.2 Brazil Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
8.3 Argentina Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Tuberculosis Vaccines Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Tuberculosis Vaccines Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Tuberculosis Vaccines Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
9.3 Turkey Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
9.4 Egypt Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
9.5 South Africa Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Tuberculosis Vaccines Sales and Market Share by Type (2015-2020)
10.2 Global Tuberculosis Vaccines Revenue and Market Share by Type (2015-2020)
10.3 Global Tuberculosis Vaccines Price by Type (2015-2020)
11 Global Tuberculosis Vaccines Market Segment by Application
11.1 Global Tuberculosis Vaccines Sales Market Share by Application (2015-2020)
11.2 Global Tuberculosis Vaccines Revenue Market Share by Application (2015-2020)
11.3 Global Tuberculosis Vaccines Price by Application (2015-2020)
12 Market Forecast
12.1 Global Tuberculosis Vaccines Sales, Revenue and Growth Rate (2021-2025)
12.2 Tuberculosis Vaccines Market Forecast by Regions (2021-2025)
12.2.1 North America Tuberculosis Vaccines Market Forecast (2021-2025)
12.2.2 Europe Tuberculosis Vaccines Market Forecast (2021-2025)
12.2.3 Asia-Pacific Tuberculosis Vaccines Market Forecast (2021-2025)
12.2.4 South America Tuberculosis Vaccines Market Forecast (2021-2025)
12.2.5 Middle East & Africa Tuberculosis Vaccines Market Forecast (2021-2025)
12.3 Tuberculosis Vaccines Market Forecast by Type (2021-2025)
12.3.1 Global Tuberculosis Vaccines Sales Forecast by Type (2021-2025)
12.3.2 Global Tuberculosis Vaccines Market Share Forecast by Type (2021-2025)
12.4 Tuberculosis Vaccines Market Forecast by Application (2021-2025)
12.4.1 Global Tuberculosis Vaccines Sales Forecast by Application (2021-2025)
12.4.2 Global Tuberculosis Vaccines Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Tuberculosis Vaccines Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Tuberculosis Vaccines by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Tuberculosis Vaccines Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Tuberculosis Vaccines Major Business
Table 9. Sanofi Tuberculosis Vaccines Total Revenue (USD Million) (2018-2019)
Table 10. Sanofi SWOT Analysis
Table 11. Sanofi Tuberculosis Vaccines Product and Services
Table 12. Sanofi Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Taj Pharmaceuticals Tuberculosis Vaccines Major Business
Table 15. Taj Pharmaceuticals Tuberculosis Vaccines Total Revenue (USD Million) (2018-2019)
Table 16. Taj Pharmaceuticals SWOT Analysis
Table 17. Taj Pharmaceuticals Tuberculosis Vaccines Product and Services
Table 18. Taj Pharmaceuticals Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline Tuberculosis Vaccines Major Business
Table 21. GlaxoSmithKline Tuberculosis Vaccines Total Revenue (USD Million) (2018-2019)
Table 22. GlaxoSmithKline SWOT Analysis
Table 23. GlaxoSmithKline Tuberculosis Vaccines Product and Services
Table 24. GlaxoSmithKline Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Merck Basic Information, Manufacturing Base and Competitors
Table 26. Merck Tuberculosis Vaccines Major Business
Table 27. Merck Tuberculosis Vaccines Total Revenue (USD Million) (2018-2019)
Table 28. Merck SWOT Analysis
Table 29. Merck Tuberculosis Vaccines Product and Services
Table 30. Merck Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. GreenSignal Bio Pharma Basic Information, Manufacturing Base and Competitors
Table 32. GreenSignal Bio Pharma Tuberculosis Vaccines Major Business
Table 33. GreenSignal Bio Pharma Tuberculosis Vaccines Total Revenue (USD Million) (2018-2019)
Table 34. GreenSignal Bio Pharma SWOT Analysis
Table 35. GreenSignal Bio Pharma Tuberculosis Vaccines Product and Services
Table 36. GreenSignal Bio Pharma Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 38. Serum Institute of India Tuberculosis Vaccines Major Business
Table 39. Serum Institute of India Tuberculosis Vaccines Total Revenue (USD Million) (2018-2019)
Table 40. Serum Institute of India SWOT Analysis
Table 41. Serum Institute of India Tuberculosis Vaccines Product and Services
Table 42. Serum Institute of India Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. China National Biotec Group Basic Information, Manufacturing Base and Competitors
Table 44. China National Biotec Group Tuberculosis Vaccines Major Business
Table 45. China National Biotec Group Tuberculosis Vaccines Total Revenue (USD Million) (2018-2019)
Table 46. China National Biotec Group SWOT Analysis
Table 47. China National Biotec Group Tuberculosis Vaccines Product and Services
Table 48. China National Biotec Group Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. IDT Biologics Basic Information, Manufacturing Base and Competitors
Table 50. IDT Biologics Tuberculosis Vaccines Major Business
Table 51. IDT Biologics Tuberculosis Vaccines Total Revenue (USD Million) (2018-2019)
Table 52. IDT Biologics SWOT Analysis
Table 53. IDT Biologics Tuberculosis Vaccines Product and Services
Table 54. IDT Biologics Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Japan BCG Lab Basic Information, Manufacturing Base and Competitors
Table 56. Japan BCG Lab Tuberculosis Vaccines Major Business
Table 57. Japan BCG Lab Tuberculosis Vaccines Total Revenue (USD Million) (2018-2019)
Table 58. Japan BCG Lab SWOT Analysis
Table 59. Japan BCG Lab Tuberculosis Vaccines Product and Services
Table 60. Japan BCG Lab Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Bavarian Nordic Basic Information, Manufacturing Base and Competitors
Table 62. Bavarian Nordic Tuberculosis Vaccines Major Business
Table 63. Bavarian Nordic Tuberculosis Vaccines Total Revenue (USD Million) (2018-2019)
Table 64. Bavarian Nordic SWOT Analysis
Table 65. Bavarian Nordic Tuberculosis Vaccines Product and Services
Table 66. Bavarian Nordic Tuberculosis Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Global Tuberculosis Vaccines Sales by Manufacturer (2018-2019) (K Doses)
Table 68. Global Tuberculosis Vaccines Revenue by Manufacturer (2018-2019) (USD Million)
Table 69. Global Tuberculosis Vaccines Sales by Regions (2015-2020) (K Doses)
Table 70. Global Tuberculosis Vaccines Sales Market Share by Regions (2015-2020)
Table 71. Global Tuberculosis Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 72. North America Tuberculosis Vaccines Sales by Countries (2015-2020) (K Doses)
Table 73. North America Tuberculosis Vaccines Sales Market Share by Countries (2015-2020)
Table 74. North America Tuberculosis Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 75. North America Tuberculosis Vaccines Revenue Market Share by Countries (2015-2020)
Table 76. Europe Tuberculosis Vaccines Sales by Countries (2015-2020) (K Doses)
Table 77. Europe Tuberculosis Vaccines Sales Market Share by Countries (2015-2020)
Table 78. Europe Tuberculosis Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 79. Asia-Pacific Tuberculosis Vaccines Sales by Regions (2015-2020) (K Doses)
Table 80. Asia-Pacific Tuberculosis Vaccines Sales Market Share by Regions (2015-2020)
Table 81. Asia-Pacific Tuberculosis Vaccines Revenue by Regions (2015-2020) (USD Million)
Table 82. South America Tuberculosis Vaccines Sales by Countries (2015-2020) (K Doses)
Table 83. South America Tuberculosis Vaccines Sales Market Share by Countries (2015-2020)
Table 84. South America Tuberculosis Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 85. South America Tuberculosis Vaccines Revenue Market Share by Countries (2015-2020)
Table 86. Middle East & Africa Tuberculosis Vaccines Sales by Countries (2015-2020) (K Doses)
Table 87. Middle East & Africa Tuberculosis Vaccines Sales Market Share by Countries (2015-2020)
Table 88. Middle East & Africa Tuberculosis Vaccines Revenue by Countries (2015-2020) (USD Million)
Table 89. Middle East & Africa Tuberculosis Vaccines Revenue Market Share by Countries (2015-2020)
Table 90. Global Tuberculosis Vaccines Sales by Type (2015-2020) (K Doses)
Table 91. Global Tuberculosis Vaccines Sales Share by Type (2015-2020)
Table 92. Global Tuberculosis Vaccines Revenue by Type (2015-2020) (USD Million)
Table 93. Global Tuberculosis Vaccines Revenue Share by Type (2015-2020)
Table 94. Global Tuberculosis Vaccines Sales by Application (2015-2020) (K Doses)
Table 95. Global Tuberculosis Vaccines Sales Share by Application (2015-2020)
Table 96. Global Tuberculosis Vaccines Sales Forecast by Regions (2021-2025) (K Doses)
Table 97. Global Tuberculosis Vaccines Market Share Forecast by Regions (2021-2025)
Table 98. Global Tuberculosis Vaccines Sales Forecast by Type (2021-2025) (K Doses)
Table 99. Global Tuberculosis Vaccines Market Share Forecast by Type (2021-2025)
Table 100. Global Tuberculosis Vaccines Sales Forecast by Application (2021-2025)
Table 101. Global Tuberculosis Vaccines Market Share Forecast by Application (2021-2025)
Table 102. Direct Channel Pros & Cons
Table 103. Indirect Channel Pros & Cons
Table 104. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Tuberculosis Vaccines Picture
Figure 2. Global Sales Market Share of Tuberculosis Vaccines by Type in 2019
Figure 3. Immunotherapeutic Vaccines Picture
Figure 4. Booster Vaccines Picture
Figure 5. Others Picture
Figure 6. Tuberculosis Vaccines Sales Market Share by Application in 2018
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Others Picture
Figure 10. Global Tuberculosis Vaccines Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Tuberculosis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Tuberculosis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Tuberculosis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Tuberculosis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Tuberculosis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Tuberculosis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Tuberculosis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Tuberculosis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Tuberculosis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Tuberculosis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Tuberculosis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Tuberculosis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Tuberculosis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Tuberculosis Vaccines Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Tuberculosis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Tuberculosis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Tuberculosis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Tuberculosis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Tuberculosis Vaccines Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Tuberculosis Vaccines Sales Market Share by Manufacturer in 2019
Figure 31. Global Tuberculosis Vaccines Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Tuberculosis Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Tuberculosis Vaccines Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Tuberculosis Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 36. Global Tuberculosis Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Tuberculosis Vaccines Revenue Market Share by Regions (2015-2020)
Figure 38. Global Tuberculosis Vaccines Revenue Market Share by Regions in 2018
Figure 39. North America Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
Figure 40. Europe Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
Figure 42. South America Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Tuberculosis Vaccines Sales and Growth Rate (2015-2020)
Figure 44. North America Tuberculosis Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Tuberculosis Vaccines Sales Market Share by Countries (2015-2020)
Figure 46. North America Tuberculosis Vaccines Sales Market Share by Countries in 2018
Figure 47. North America Tuberculosis Vaccines Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Tuberculosis Vaccines Revenue Market Share by Countries in 2018
Figure 49. United States Tuberculosis Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 50. Canada Tuberculosis Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 51. Mexico Tuberculosis Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 52. Europe Tuberculosis Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Tuberculosis Vaccines Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Tuberculosis Vaccines Revenue Market Share by Countries in 2019
Figure 55. Germany Tuberculosis Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 56. UK Tuberculosis Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 57. France Tuberculosis Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 58. Russia Tuberculosis Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 59. Italy Tuberculosis Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 60. Asia-Pacific Tuberculosis Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Tuberculosis Vaccines Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Tuberculosis Vaccines Revenue Market Share by Regions 2019
Figure 63. China Tuberculosis Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 64. Japan Tuberculosis Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 65. Korea Tuberculosis Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 66. India Tuberculosis Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 67. Southeast Asia Tuberculosis Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 68. South America Tuberculosis Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Tuberculosis Vaccines Sales Market Share by Countries in 2019
Figure 70. South America Tuberculosis Vaccines Revenue Market Share by Countries in 2019
Figure 71. Brazil Tuberculosis Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 72. Argentina Tuberculosis Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 73. Middle East and Africa Tuberculosis Vaccines Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Tuberculosis Vaccines Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Tuberculosis Vaccines Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Tuberculosis Vaccines Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Tuberculosis Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 78. Egypt Tuberculosis Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 79. Turkey Tuberculosis Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 80. South Africa Tuberculosis Vaccines Sales and Growth Rate (2015-2020) (K Doses)
Figure 81. Global Tuberculosis Vaccines Sales and Growth Rate (2021-2025) (K Doses)
Figure 82. Global Tuberculosis Vaccines Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Tuberculosis Vaccines Market Forecast (2021-2025) (K Doses)
Figure 84. Europe Sales Tuberculosis Vaccines Market Forecast (2021-2025) (K Doses)
Figure 85. Asia-Pacific Sales Tuberculosis Vaccines Market Forecast (2021-2025) (K Doses)
Figure 86. South America Sales Tuberculosis Vaccines Market Forecast (2021-2025) (K Doses)
Figure 87. Middle East & Africa Sales Tuberculosis Vaccines Market Forecast (2021-2025) (K Doses)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
結核ワクチン治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Tuberculosis Vaccine Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Tuberculosis V…- DPTワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global DPT Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The DPT Vaccines market report provi…
- 予防B型肝炎ウイルスワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Prophylactic Hepatitis B Virus Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Proph…
- mRNAワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The mRNA Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 細菌ワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Bacterial Vaccines market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Bacterial Vaccines market …